Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

530617

SAMPRE

img img img img
No Data Available

SAMPRE NUTRITIONS LTD. Share Price Update

As of the latest trading session, SAMPRE NUTRITIONS LTD. share price is currently at ₹ 26.09, which is up by ₹ 0.12 from its previous closing. Today, the stock has fluctuated between ₹ 25.00 and ₹ 27.20. Over the past year, SAMPRE NUTRITIONS LTD. has achieved a return of 60.86 %. In the last month alone, the return has been -17.03 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SAMPRE NUTRITIONS LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    227.70

  • P/E Ratio (TTM)

    -37.23

  • Beta

    0.32

  • Book Value / share

    11.21

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.89

info icon alternate text

SAMPRE NUTRITIONS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 10.00
Operating Expense 8.94
Net Profit 0.89
Net Profit Margin (%) 8.90
Earnings Per Share (EPS) 0.41
EBITDA 1.95
Effective Tax Rate (%) 16.03
Particulars JUN 2025 (Values in Cr)
Revenue 10.87
Operating Expense 10.18
Net Profit 0.71
Net Profit Margin (%) 6.53
Earnings Per Share (EPS) 0.34
EBITDA 1.41
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 7.77
Operating Expense 15.07
Net Profit -7.14
Net Profit Margin (%) -91.89
Earnings Per Share (EPS) -3.40
EBITDA -5.99
Effective Tax Rate (%) -2.14
Particulars DEC 2024 (Values in Cr)
Revenue 5.58
Operating Expense 6.16
Net Profit -0.54
Net Profit Margin (%) -9.67
Earnings Per Share (EPS) -0.30
EBITDA 0.48
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 7.27
Operating Expense 7.15
Net Profit 0.12
Net Profit Margin (%) 1.65
Earnings Per Share (EPS) 0.18
EBITDA 1.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 25.12
Operating Expense 32.66
Net Profit -7.31
Net Profit Margin (%) -29.10
Earnings Per Share (EPS) -3.48
EBITDA -3.36
Effective Tax Rate (%) -2.09
Particulars MAR 2024 (Values in Cr)
Revenue 25.15
Operating Expense 24.70
Net Profit 0.31
Net Profit Margin (%) 1.23
Earnings Per Share (EPS) 0.43
EBITDA 4.32
Effective Tax Rate (%) 45.61
Particulars MAR 2023 (Values in Cr)
Revenue 37.11
Operating Expense 36.76
Net Profit 0.35
Net Profit Margin (%) 0.94
Earnings Per Share (EPS) 0.61
EBITDA 4.13
Effective Tax Rate (%) 16.66
Particulars MAR 2022 (Values in Cr)
Revenue 23.13
Operating Expense 23.03
Net Profit 0.31
Net Profit Margin (%) 1.34
Earnings Per Share (EPS) 0.64
EBITDA 3.77
Effective Tax Rate (%) 16.21
Particulars MAR 2021 (Values in Cr)
Revenue 18.23
Operating Expense 18.15
Net Profit 0.08
Net Profit Margin (%) 0.43
Earnings Per Share (EPS) 0.16
EBITDA 3.46
Effective Tax Rate (%) 27.27
Particulars MAR 2025 (Values in Cr)
Book Value / Share 42.44
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.30
EBITDA Margin -13.85
Particulars MAR 2024 (Values in Cr)
Book Value / Share 26.75
ROE % 1.05
ROCE % 6.19
Total Debt to Total Equity 0.79
EBITDA Margin 16.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.39
ROE % 1.65
ROCE % 6.09
Total Debt to Total Equity 0.79
EBITDA Margin 11.13
Particulars MAR 2025 (Values in Cr)
Book Value / Share 38.14
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.30
EBITDA Margin -13.38
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.29
ROE % 1.42
ROCE % 6.39
Total Debt to Total Equity 0.78
EBITDA Margin 17.18
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.39
ROE % 2.17
ROCE % 6.58
Total Debt to Total Equity 1.18
EBITDA Margin 11.13
Particulars MAR 2022 (Values in Cr)
Book Value / Share 23.01
ROE % 2.83
ROCE % 6.65
Total Debt to Total Equity 1.94
EBITDA Margin 16.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 22.37
ROE % 0.74
ROCE % 5.25
Total Debt to Total Equity 1.93
EBITDA Margin 18.98
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.23
Total Assets 115.43
Total Liabilities 115.43
Total Equity 90.87
Share Outstanding 21006855
Price to Book Ratio 0.59
Return on Assets (%) -6.64
Return on Capital (%) -7.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.28
Total Assets 44.75
Total Liabilities 44.75
Total Equity 22.46
Share Outstanding 7270000
Price to Book Ratio 2.41
Return on Assets (%) 0.51
Return on Capital (%) 0.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 43.58
Total Liabilities 43.58
Total Equity 21.15
Share Outstanding 6870000
Price to Book Ratio 3.33
Return on Assets (%) 0.79
Return on Capital (%) 0.92
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 117.07
Total Liabilities 117.07
Total Equity 92.56
Share Outstanding 21006855
Price to Book Ratio 0.59
Return on Assets (%) -6.24
Return on Capital (%) -6.68
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 44.83
Total Liabilities 44.83
Total Equity 22.54
Share Outstanding 7270000
Price to Book Ratio 2.41
Return on Assets (%) 0.69
Return on Capital (%) 0.77
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 43.58
Total Liabilities 43.58
Total Equity 21.15
Share Outstanding 6870000
Price to Book Ratio 3.33
Return on Assets (%) 0.79
Return on Capital (%) 0.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 37.70
Total Liabilities 37.70
Total Equity 11.09
Share Outstanding 4820000
Price to Book Ratio 1.41
Return on Assets (%) 0.81
Return on Capital (%) 0.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 38.28
Total Liabilities 38.28
Total Equity 10.78
Share Outstanding 4820000
Price to Book Ratio 0.65
Return on Assets (%) 0.19
Return on Capital (%) 0.24
Particulars MAR 2025 (Values in Cr)
Net Income -7.52
Cash from Operations 0.19
Cash from Investing -75.16
Cash from Financing 75.02
Net change in Cash -0.05
Free Cash Flow 0.46
Particulars MAR 2024 (Values in Cr)
Net Income 0.48
Cash from Operations 3.73
Cash from Investing -3.69
Cash from Financing -0.09
Net change in Cash 0.15
Free Cash Flow 7.44
Particulars MAR 2023 (Values in Cr)
Net Income 0.41
Cash from Operations 1.13
Cash from Investing -4.31
Cash from Financing 3.48
Net change in Cash 0.04
Free Cash Flow 5.54
Particulars MAR 2025 (Values in Cr)
Net Income -7.16
Cash from Operations 0.19
Cash from Investing -75.16
Cash from Financing 75.02
Net change in Cash -0.05
Free Cash Flow 0.47
Particulars MAR 2024 (Values in Cr)
Net Income 0.56
Cash from Operations 3.81
Cash from Investing -3.95
Cash from Financing -0.09
Net change in Cash -0.01
Free Cash Flow 7.52
Particulars MAR 2023 (Values in Cr)
Net Income 0.41
Cash from Operations 1.13
Cash from Investing -4.31
Cash from Financing 3.48
Net change in Cash 0.04
Free Cash Flow 5.54
Particulars MAR 2022 (Values in Cr)
Net Income 0.37
Cash from Operations 2.72
Cash from Investing -0.76
Cash from Financing -1.65
Net change in Cash -0.01
Free Cash Flow 4.03
Particulars MAR 2021 (Values in Cr)
Net Income 0.10
Cash from Operations 0.02
Cash from Investing -0.89
Cash from Financing 0.32
Net change in Cash -0.75
Free Cash Flow 2.38
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5981.65 62.19 38.59 144078.98 4506.50 / 6336.95
NESTLE INDIA LIMITED 1279.60 83.63 55.64 246747.10 1057.50 / 1310.50
FOODS & INNS LIMITED 68.95 16.07 0.92 506.19 67.78 / 128.79
HINDUSTAN UNILEVER LTD. 2347.80 52.15 11.32 551637.04 2101.12 / 2734.31
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5981.65 62.58 44.08 144078.98 4506.50 / 6336.95
COLGATE PALMOLIVE LTD. 2089.35 42.86 35.91 56827.32 2052.00 / 2974.80
NESTLE INDIA LIMITED 1279.60 82.40 54.06 246747.10 1057.50 / 1310.50
FOODS & INNS LIMITED 68.95 14.58 0.91 506.19 67.78 / 128.79

SAMPRE NUTRITIONS LTD. shareholding pattern

Holding

84.55%
15.44%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SAMPRE NUTRITIONS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
26.06 0.34 redarrow
red-green-graph indicator
9 Bearish
7 Bullish
  • 5 Days 25.40
  • 26 Days 27.10
  • 10 Days 25.40
  • 50 Days 28.40
  • 12 Days 25.50
  • 100 Days 26.60
  • 20 Days 26.40
  • 200 Days 22.40
25.41 PIVOT

First Support

24.81

First Resistance

26.56

Second Support

23.66

Second Resistance

27.16

Third Support

23.06

Third Resistance

28.31

RSI

44.40

ADX

30.34

MACD

-1.54

Williams % R

-53.31

Commodity Channel Index (CCI)

17.74

Date

2026-01-02

Week

207323.00

Same Day

166761.00

Month

182382.00

1 Year

0.32

3 Year

0.44

Over 1 Month

-17.03%

down

Over 1 Year

60.86%

down

Over 3 Months

-17.37%

down

Over 3 Years

-11.29%

down

Over 6 Months

191.17%

down

Over 5 Years

34.59%

down

SAMPRE NUTRITIONS LTD. Corporate Actions

Ex-Date Ex-Bonus Ratio
14 Nov 2025 14 Nov 2025 1:1
Ex-Date Old FV NEW FV Record Date
14 Nov 2025 10.0 5.0 14 Nov 2025

SAMPRE NUTRITIONS LTD. Share Price

Sampre Nutritions Ltd., incorporated in 1991 was promoted by The Gurbani Group, having its works at Medchal, in Andhra Pradesh. The Company is into the activity of manufacturing of Sugar Candies. The Company has been manufacturing candy products for its major customer, Cadbury India Ltd since August 1996. In 2000, it entered into agreement to manufacture 'DAIRY MILK ECLAIRS'.

During 1999, the Company commissioned two new projects for manufacture of Jelly in cups under the brand name 'GOLLUM' and 'Mr POPS'.

The company was also into the production of HERICOF Cough Lozenges for Ranbaxy Laboratories Ltd, whereby it manufactures CHESTO cough drops for export to its customer 'The Maharaja Organisation Ltd' of Sri Lanka.

During 2000, the Company got a major break-through during as it has commenced supplying confectionery products from April 2000 to the various depots of the Indian Airlines across the country

The Company launched 6 flavors of Hard Boiled Candy under 'Sampre' Brand in first phase during the year 2018.

During the year 2017, the Company was working as contract manufacturers of 'Eclairs' for Mondelez India Foods Private Limited (Formerly Cadbury India Ltd) and after expansion of production capacities, it became exclusive partner of Modelez India for manufacture of eclairs for Domestic and Export Market in 2022.

The Company set up wholly owned subsidiaries namely 'SAMPRE NUTRITIONS FZE CO' in Dubai, United Arab Emirates & 'SAMPRE NUTRITIONS HOLDING LIMITED' in England, United Kingdom during the year 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 1991
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sampre Nutritions Ltd?

Answer Field

Sampre Nutritions Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 26.06 as on Jan 02 2026 03:29 PM.

What is the Market Cap of Sampre Nutritions Ltd Share?

Answer Field

The market cap of Sampre Nutritions Ltd for NSE ₹ 0.00 & for BSE ₹ 227.70 as on Jan 02 2026 03:29 PM.

What is the 52 Week High and Low of Sampre Nutritions Ltd?

Answer Field

The 52 Week High and Low of Sampre Nutritions Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 42.33 and ₹ 5.23.

What is 1 year return for Sampre Nutritions Ltd?

Answer Field

The 1 year returns on the stock has been 60.86%.

What is the P/E Ratio of Sampre Nutritions Ltd Share?

Answer Field

As on Jan 02 2026 03:29 PM the price-to-earnings (PE) ratio for Sampre Nutritions Ltd share is -37.23.

What is the PB ratio of Sampre Nutritions Ltd Share?

Answer Field

As on Jan 02 2026 03:29 PM, the price-to-book (PB) ratio for Sampre Nutritions Ltd share is 11.21.

How to Buy Sampre Nutritions Ltd Share?

Answer Field

You can trade in Sampre Nutritions Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sampre Nutritions Ltd Share on Bajaj Broking App?

Answer Field

To buy Sampre Nutritions Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sampre Nutritions Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59